Elad Anter, MD, FACC, is an electrophysiologist, scientist, and innovator in the field of catheter ablation, specializing in catheter ablation of atrial fibrillation and ventricular tachycardia.

Dr. Anter earned his undergraduate and medical degrees from Hebrew University in Jerusalem, Israel. He relocated to the United States for a postdoctoral research fellowship in molecular biology at Boston University and remained in Boston to complete his Internal Medicine residency at the Brigham and Women’s Hospital. He continued his training as a fellow in Cardiovascular Medicine at the University of Pennsylvania, Philadelphia, where he then completed a subspecialty training in Cardiac Electrophysiology.    

Dr. Anter was then recruited to the Beth Israel Deaconess Medical Center in Boston by the late Dr. Mark E. Josephson, a pioneer in the field of Cardiac Electrophysiology. Drs. Anter and Josephson worked closely together and have made significant contributions to the field of Cardiac Electrophysiology. During this tenure, Dr. Anter established a translational research laboratory that focuses on studying mechanisms of arrhythmias and translating this knowledge into innovations that improve patient care. This research laboratory has been pivotal in describing mechanisms of reentrant ventricular tachycardias, developing new mapping catheters and ablation technologies, that have since become standard of care.

Dr. Anter dedicates significant time for teaching and mentoring fellows. “I’ve learned a lot from my own mentors who were instrumental in shaping me, and I share what I’ve learned with my mentees,” says Dr. Anter. He has published nearly 100 original articles in high-impact peer-reviewed medical journals, and frequently speaks at national and international medical meetings on his research and clinical interests.